XML 90 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Intangible Assets
9 Months Ended
Jun. 28, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
Goodwill and Intangible Assets
Goodwill
A rollforward of goodwill activity by reportable segment from September 28, 2013 to June 28, 2014 is as follows:
 
 
Diagnostics
 
Breast Health
 
GYN Surgical
 
Skeletal Health
 
Total
Balance at September 28, 2013
$
1,153.5

 
$
636.4

 
$
1,016.4

 
$
8.2

 
$
2,814.5

Disposition of a portion of a reporting unit
(0.2
)
 

 

 

 
(0.2
)
Tax adjustments
(0.6
)
 

 

 

 
(0.6
)
Foreign currency and other
(0.6
)
 
(1.7
)
 
(0.3
)
 

 
(2.6
)
Balance at June 28, 2014
$
1,152.1


$
634.7


$
1,016.1


$
8.2


$
2,811.1


Intangible Assets
Intangible assets consisted of the following:
 
Description
As of June 28, 2014
 
As of September 28, 2013
Gross
Carrying
Value
 
Accumulated
Amortization
 
Gross
Carrying
Value
 
Accumulated
Amortization
Developed technology
$
3,969.9

 
$
1,317.6

 
$
4,009.0

 
$
1,094.5

In-process research and development
23.0

 

 
24.0

 

Customer relationships and contracts
1,101.9

 
362.5

 
1,101.9

 
296.5

Trade names
236.8

 
98.8

 
238.1

 
81.8

Patents
14.1

 
8.8

 
13.0

 
8.5

Business licenses
2.6

 
1.9

 
2.6

 
0.6

 
$
5,348.3


$
1,789.6


$
5,388.6


$
1,481.9


The Company recorded impairment charges of $26.6 million and $0.5 million to developed technology and trade names, respectively, in the second quarter of fiscal 2014. In addition, the Company periodically re-evaluates the lives of its definite-lived intangible assets, and in the second quarter of fiscal 2014 shortened the life of certain corporate trade names, which will be phased out. Additionally, in the third quarter of fiscal 2014, the Company shortened the life of certain intangible assets associated with the MRI breast coils product line.
During the third quarter of fiscal 2013, the Company determined that a developed technology asset was impaired and recorded a $1.7 million charge to cost of product revenues to record the asset at its estimated fair value.
The estimated remaining amortization expense as of June 28, 2014 for each of the five succeeding fiscal years is as follows:

Remainder of Fiscal 2014
$
109.5

Fiscal 2015
$
414.6

Fiscal 2016
$
374.5

Fiscal 2017
$
365.4

Fiscal 2018
$
354.9